PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE

phentermine and topiramate
$3.6356per EA
DEA Schedule CIV

Strength

15; 92 mg/1; mg/1

NDC

66993078330

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022580

On Market Since

6/1/2025

Pharmacological Classes

Appetite Suppression
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Increased Sympathetic Activity
Sympathomimetic Amine Anorectic

Price History

1W

0.0%

1M

-2.7%

3M

-1.2%

6M

+13.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

+15.6%

Generic Alternatives

1 alternative • Same active ingredient